世界のクリニカルリスクグルーピングソリューション市場は、2025年に664百万米ドルと算定されており、2026年には711百万米ドルとなる見通しです。2026年から2032年の期間においては年平均成長率（CAGR）7.1%で推移し、2032年には1074百万米ドルに達すると予測されています。

本レポートは、クリニカルリスクグルーピングソリューションメーカー、新規参入企業、および業界バリューチェーン全体の企業に対し、市場全体およびサブセグメント別の収益、生産量、平均価格に関する情報を、企業別、タイプ別、用途別、地域別に提供します。
世界のクリニカルリスクグルーピングソリューション市場について、定量的・定性的分析を交えた包括的な概観を提供し、企業関係者が成長戦略の策定、競争環境の評価、現行市場における自社の位置付けの分析、クリニカルリスクグルーピングソリューションに関する情報に基づいたビジネス判断を行うことを支援します。クリニカルリスクグルーピングソリューション市場の規模、推定値及び予測値の観点から提示し、2025年を基準年として、2021年から2032年までの過去データ及び予測データを収録しております。

報告対象範囲
売上高・数量予測、企業シェア、競争環境、成長要因および市場トレンド

市場セグメンテーション
企業一覧
3M Corporation
Cerner Corporation
Optum (UnitedHealth Group)
Epic Systems Corporation
Oracle Cerner
IBM Corporation
SAS Institute Inc.
Veradigm (Allscripts)
Health Catalyst
Cotiviti
IQVIA
Siemens Healthineers
Philips Healthcare
Dedalus
Change Healthcare
Yidu Tech
Ping An Healthcare
Toshiba


タイプ別
Scorecard and Visualization Tools
Dashboard Analysis
Risk Report


用途別
Hospital
Nursing Center
Other


製品カテゴリー


市場セグメント
Low-Risk Group: Readmission Rate <5%
Medium-Risk Group: Readmission Rate 5%–15%
High-Risk Group: Readmission Rate >15%

地域別
北米（アメリカ、カナダ、メキシコ）
欧州（ドイツ、フランス、イギリス、イタリアなど）
アジア太平洋（中国、日本、韓国、東南アジア、インドなど）
南米（ブラジルなど）
中東・アフリカ（トルコ、GCC諸国、アフリカなど）
本レポートは、世界のクリニカルリスクグルーピングソリューション市場を包括的にセグメント化しております。地域別市場規模、タイプ別、用途別、企業別の市場規模も提供されます。より深い洞察を得るため、競争環境、主要競合他社、それぞれの市場順位をプロファイリングし、技術動向や新製品開発についても論じております。

本レポートの構成
第1章：クリニカルリスクグルーピングソリューションの定義および調査範囲を明確化し、市場セグメント（タイプ別、用途別など）の概要を提示します。各セグメントの市場規模と将来の成長可能性を網羅し、現在の市場状況の概要を提供するとともに、短期・中期・長期の発展トレンドを分析します
第2章：クリニカルリスクグルーピングソリューションメーカーの競争環境について、価格、生産量、価値ベースの市場シェア、最新の開発計画、合併・買収情報を含め詳細に分析します
第3章：クリニカルリスクグルーピングソリューションの生産量／生産高および価値を地域・国別に検証し、今後6年間の各地域の市場規模と成長可能性について定量的な評価を提供します
第4章：地域および国レベルでのクリニカルリスクグルーピングソリューションの消費動向を分析します。各地域および主要国における市場規模と成長可能性を定量化し、市場開発状況、見通し、対応可能な市場規模、国内生産量を概説します
第5章：クリニカルリスクグルーピングソリューションに基づくタイプ別市場セグメントの構造を整理し、各セグメントの市場規模と成長ポテンシャルを明確化することで、企業・投資家によるブルーオーシャン機会の発見を支援します
第6章：用途別にクリニカルリスクグルーピングソリューションの市場セグメントを整理し、各分野の市場規模、成長ポテンシャル、需要拡大余地を提示することで、下流市場における有望な参入機会や競争優位の確立に向けた判断材料を提供します
第7章：クリニカルリスクグルーピングソリューションの主要プレイヤーを分析し、主要企業の基本情報（製品生産量／生産高、価値、価格、粗利益率、製品ポートフォリオ／新製品導入、最近の動向）を詳細に説明します
第8章：クリニカルリスクグルーピングソリューションの上流および下流セグメントを含む業界バリューチェーンをレビューします
第9章：クリニカルリスクグルーピングソリューション市場の動向と最新トレンドについて議論します。これには、メーカーにとっての推進要因、制約要因、課題、リスク、米国関税、関連政策分析が含まれます
第10章：主な調査結果と結論をまとめます
第11章：付録

The global Clinical Risk Grouping Solutions market was valued at US$ 664 million in 2025 and is anticipated to reach US$ 1074 million by 2032, at a CAGR of 7.1% from 2026 to 2032.

Clinical Risk Grouping Solutions are analytical systems that utilize artificial intelligence, machine learning, statistical modeling, and clinical rule frameworks to stratify patient populations by health risk, predict disease risks, and optimize the allocation of medical resources. By integrating electronic medical records (EMR), laboratory and imaging data, medication records, genetic information, and health behavior data, these solutions assign risk scores and manage patients within specific categories—such as low, medium, high, and very high-risk groups. Their primary objective is to enable healthcare institutions to implement precision medical management, stratified chronic disease care, inpatient risk prediction, readmission risk control, and cost optimization. Consequently, they enhance care quality, reduce costs, and optimize resource allocation, finding widespread application in hospital administration, insurance payment management, public health, and health management.

The global landscape for clinical risk grouping solutions is characterized by North American leadership, standardized advancement in Europe, and rapid growth in the Asia-Pacific region. The North American market is primarily driven by insurance payment systems and value-based care models, with applications focused on chronic disease management, readmission risk prediction, cost containment, and population health management. The European market emphasizes regulatory compliance, data privacy protection, and the optimization of public healthcare system efficiency. Meanwhile, the Asia-Pacific region is experiencing surging demand fueled by aging populations, the rising burden of chronic diseases, and the digital transformation of healthcare. The market is currently transitioning from traditional rule-based risk stratification to AI-driven dynamic risk prediction and real-time population health management; clients increasingly prioritize prediction accuracy, clinical interpretability, data integration capabilities, and the optimization of payment efficiency. Future trends include real-time AI risk scoring, clinical risk prediction based on large-scale models, multimodal health data fusion, personalized health intervention recommendations, and integration with health insurance payment models. Key challenges include a lack of unified medical data standards, difficulties in cross-institutional data sharing, insufficient model interpretability, lengthy clinical validation cycles, and strict privacy compliance regulations. The industry's average gross margin typically ranges from 50% to 75%; standardized SaaS-based risk grouping platforms generally command higher margins, whereas customized system integration and clinical implementation projects yield relatively lower margins.

This report delivers a comprehensive overview of the global Clinical Risk Grouping Solutions market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Clinical Risk Grouping Solutions. The Clinical Risk Grouping Solutions market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Clinical Risk Grouping Solutions market comprehensively. Regional market sizes by Type, by Application, by Technology, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Clinical Risk Grouping Solutions manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation
By Company
3M Corporation
Cerner Corporation
Optum (UnitedHealth Group)
Epic Systems Corporation
Oracle Cerner
IBM Corporation
SAS Institute Inc.
Veradigm (Allscripts)
Health Catalyst
Cotiviti
IQVIA
Siemens Healthineers
Philips Healthcare
Dedalus
Change Healthcare
Yidu Tech
Ping An Healthcare
Toshiba

Segment by Type
Scorecard and Visualization Tools
Dashboard Analysis
Risk Report

Segment by Technology
Rule-based Risk Models
Statistical Risk Models
Machine Learning Risk Models
AI Deep Learning Risk Models

Segment by Risk Group
Low-Risk Group: Readmission Rate <5%
Medium-Risk Group: Readmission Rate 5%–15%
High-Risk Group: Readmission Rate >15%

Segment by Application
Hospital
Nursing Center
Other

By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Technology, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Clinical Risk Grouping Solutions companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Risk Grouping Solutions Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Scorecard and Visualization Tools
1.2.3 Dashboard Analysis
1.2.4 Risk Report
1.3 Market by Technology
1.3.1 Global Clinical Risk Grouping Solutions Market Size Growth Rate by Technology: 2021 vs 2025 vs 2032
1.3.2 Rule-based Risk Models
1.3.3 Statistical Risk Models
1.3.4 Machine Learning Risk Models
1.3.5 AI Deep Learning Risk Models
1.4 Market by Risk Group
1.4.1 Global Clinical Risk Grouping Solutions Market Size Growth Rate by Risk Group: 2021 vs 2025 vs 2032
1.4.2 Low-Risk Group: Readmission Rate <5%
1.4.3 Medium-Risk Group: Readmission Rate 5%–15%
1.4.4 High-Risk Group: Readmission Rate >15%
1.5 Market by Application
1.5.1 Global Clinical Risk Grouping Solutions Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Hospital
1.5.3 Nursing Center
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends
2.1 Global Clinical Risk Grouping Solutions Market Perspective (2021–2032)
2.2 Global Clinical Risk Grouping Solutions Growth Trends by Region
2.2.1 Global Clinical Risk Grouping Solutions Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Clinical Risk Grouping Solutions Historic Market Size by Region (2021–2026)
2.2.3 Clinical Risk Grouping Solutions Forecasted Market Size by Region (2027–2032)
2.3 Clinical Risk Grouping Solutions Market Dynamics
2.3.1 Clinical Risk Grouping Solutions Industry Trends
2.3.2 Clinical Risk Grouping Solutions Market Drivers
2.3.3 Clinical Risk Grouping Solutions Market Challenges
2.3.4 Clinical Risk Grouping Solutions Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Clinical Risk Grouping Solutions Players by Revenue
3.1.1 Global Top Clinical Risk Grouping Solutions Players by Revenue (2021–2026)
3.1.2 Global Clinical Risk Grouping Solutions Revenue Market Share by Players (2021–2026)
3.2 Global Top Clinical Risk Grouping Solutions Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Clinical Risk Grouping Solutions Revenue
3.4 Global Clinical Risk Grouping Solutions Market Concentration Ratio
3.4.1 Global Clinical Risk Grouping Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Risk Grouping Solutions Revenue in 2025
3.5 Global Key Players of Clinical Risk Grouping Solutions Head Offices and Areas Served
3.6 Global Key Players of Clinical Risk Grouping Solutions, Products and Applications
3.7 Global Key Players of Clinical Risk Grouping Solutions, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans

4 Clinical Risk Grouping Solutions Breakdown Data by Type
4.1 Global Clinical Risk Grouping Solutions Historic Market Size by Type (2021–2026)
4.2 Global Clinical Risk Grouping Solutions Forecasted Market Size by Type (2027–2032)

5 Clinical Risk Grouping Solutions Breakdown Data by Application
5.1 Global Clinical Risk Grouping Solutions Historic Market Size by Application (2021–2026)
5.2 Global Clinical Risk Grouping Solutions Forecasted Market Size by Application (2027–2032)

6 North America
6.1 North America Clinical Risk Grouping Solutions Market Size (2021–2032)
6.2 North America Clinical Risk Grouping Solutions Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Clinical Risk Grouping Solutions Market Size by Country (2021–2026)
6.4 North America Clinical Risk Grouping Solutions Market Size by Country (2027–2032)
6.5 United States
6.6 Canada

7 Europe
7.1 Europe Clinical Risk Grouping Solutions Market Size (2021–2032)
7.2 Europe Clinical Risk Grouping Solutions Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Clinical Risk Grouping Solutions Market Size by Country (2021–2026)
7.4 Europe Clinical Risk Grouping Solutions Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland

8 Asia-Pacific
8.1 Asia-Pacific Clinical Risk Grouping Solutions Market Size (2021–2032)
8.2 Asia-Pacific Clinical Risk Grouping Solutions Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Clinical Risk Grouping Solutions Market Size by Region (2021–2026)
8.4 Asia-Pacific Clinical Risk Grouping Solutions Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand

9 Latin America
9.1 Latin America Clinical Risk Grouping Solutions Market Size (2021–2032)
9.2 Latin America Clinical Risk Grouping Solutions Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Clinical Risk Grouping Solutions Market Size by Country (2021–2026)
9.4 Latin America Clinical Risk Grouping Solutions Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Clinical Risk Grouping Solutions Market Size (2021–2032)
10.2 Middle East & Africa Clinical Risk Grouping Solutions Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Clinical Risk Grouping Solutions Market Size by Country (2021–2026)
10.4 Middle East & Africa Clinical Risk Grouping Solutions Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE

11 Key Players Profiles
11.1 3M Corporation
11.1.1 3M Corporation Company Details
11.1.2 3M Corporation Business Overview
11.1.3 3M Corporation Clinical Risk Grouping Solutions Introduction
11.1.4 3M Corporation Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.1.5 3M Corporation Recent Development
11.2 Cerner Corporation
11.2.1 Cerner Corporation Company Details
11.2.2 Cerner Corporation Business Overview
11.2.3 Cerner Corporation Clinical Risk Grouping Solutions Introduction
11.2.4 Cerner Corporation Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.2.5 Cerner Corporation Recent Development
11.3 Optum (UnitedHealth Group)
11.3.1 Optum (UnitedHealth Group) Company Details
11.3.2 Optum (UnitedHealth Group) Business Overview
11.3.3 Optum (UnitedHealth Group) Clinical Risk Grouping Solutions Introduction
11.3.4 Optum (UnitedHealth Group) Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.3.5 Optum (UnitedHealth Group) Recent Development
11.4 Epic Systems Corporation
11.4.1 Epic Systems Corporation Company Details
11.4.2 Epic Systems Corporation Business Overview
11.4.3 Epic Systems Corporation Clinical Risk Grouping Solutions Introduction
11.4.4 Epic Systems Corporation Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.4.5 Epic Systems Corporation Recent Development
11.5 Oracle Cerner
11.5.1 Oracle Cerner Company Details
11.5.2 Oracle Cerner Business Overview
11.5.3 Oracle Cerner Clinical Risk Grouping Solutions Introduction
11.5.4 Oracle Cerner Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.5.5 Oracle Cerner Recent Development
11.6 IBM Corporation
11.6.1 IBM Corporation Company Details
11.6.2 IBM Corporation Business Overview
11.6.3 IBM Corporation Clinical Risk Grouping Solutions Introduction
11.6.4 IBM Corporation Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.6.5 IBM Corporation Recent Development
11.7 SAS Institute Inc.
11.7.1 SAS Institute Inc. Company Details
11.7.2 SAS Institute Inc. Business Overview
11.7.3 SAS Institute Inc. Clinical Risk Grouping Solutions Introduction
11.7.4 SAS Institute Inc. Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.7.5 SAS Institute Inc. Recent Development
11.8 Veradigm (Allscripts)
11.8.1 Veradigm (Allscripts) Company Details
11.8.2 Veradigm (Allscripts) Business Overview
11.8.3 Veradigm (Allscripts) Clinical Risk Grouping Solutions Introduction
11.8.4 Veradigm (Allscripts) Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.8.5 Veradigm (Allscripts) Recent Development
11.9 Health Catalyst
11.9.1 Health Catalyst Company Details
11.9.2 Health Catalyst Business Overview
11.9.3 Health Catalyst Clinical Risk Grouping Solutions Introduction
11.9.4 Health Catalyst Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.9.5 Health Catalyst Recent Development
11.10 Cotiviti
11.10.1 Cotiviti Company Details
11.10.2 Cotiviti Business Overview
11.10.3 Cotiviti Clinical Risk Grouping Solutions Introduction
11.10.4 Cotiviti Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.10.5 Cotiviti Recent Development
11.11 IQVIA
11.11.1 IQVIA Company Details
11.11.2 IQVIA Business Overview
11.11.3 IQVIA Clinical Risk Grouping Solutions Introduction
11.11.4 IQVIA Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.11.5 IQVIA Recent Development
11.12 Siemens Healthineers
11.12.1 Siemens Healthineers Company Details
11.12.2 Siemens Healthineers Business Overview
11.12.3 Siemens Healthineers Clinical Risk Grouping Solutions Introduction
11.12.4 Siemens Healthineers Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.12.5 Siemens Healthineers Recent Development
11.13 Philips Healthcare
11.13.1 Philips Healthcare Company Details
11.13.2 Philips Healthcare Business Overview
11.13.3 Philips Healthcare Clinical Risk Grouping Solutions Introduction
11.13.4 Philips Healthcare Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.13.5 Philips Healthcare Recent Development
11.14 Dedalus
11.14.1 Dedalus Company Details
11.14.2 Dedalus Business Overview
11.14.3 Dedalus Clinical Risk Grouping Solutions Introduction
11.14.4 Dedalus Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.14.5 Dedalus Recent Development
11.15 Change Healthcare
11.15.1 Change Healthcare Company Details
11.15.2 Change Healthcare Business Overview
11.15.3 Change Healthcare Clinical Risk Grouping Solutions Introduction
11.15.4 Change Healthcare Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.15.5 Change Healthcare Recent Development
11.16 Yidu Tech
11.16.1 Yidu Tech Company Details
11.16.2 Yidu Tech Business Overview
11.16.3 Yidu Tech Clinical Risk Grouping Solutions Introduction
11.16.4 Yidu Tech Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.16.5 Yidu Tech Recent Development
11.17 Ping An Healthcare
11.17.1 Ping An Healthcare Company Details
11.17.2 Ping An Healthcare Business Overview
11.17.3 Ping An Healthcare Clinical Risk Grouping Solutions Introduction
11.17.4 Ping An Healthcare Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.17.5 Ping An Healthcare Recent Development
11.18 Toshiba
11.18.1 Toshiba Company Details
11.18.2 Toshiba Business Overview
11.18.3 Toshiba Clinical Risk Grouping Solutions Introduction
11.18.4 Toshiba Revenue in Clinical Risk Grouping Solutions Business (2021–2026)
11.18.5 Toshiba Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer